Google seeks approval to release 64M sterile mosquitoes to combat disease transmission

Mosquito-borne diseases kill 700,000 to 1 million people annually worldwide, with dengue, malaria, yellow fever, and Zika causing tens of thousands of deaths yearly.
Nature does the work for you—the population collapses on its own.
How sterile insect releases work without pesticides or genetic modification.

Of all the creatures that share this Earth with us, none has claimed more human lives than the mosquito — a fact that has driven scientists, governments, and now a technology giant to seek a new kind of answer. Google's Project Debug has petitioned American authorities to release 64 million laboratory-bred, sterile male mosquitoes across California and Florida over two years, using a naturally occurring bacterium called Wolbachia to quietly collapse the breeding cycles of disease-carrying wild populations. The method carries no toxins, no genetic alteration, and no bite — only the patient arithmetic of overwhelmed reproduction. It is, in essence, an attempt to use life itself as a shield against the diseases life transmits.

  • Mosquitoes kill up to one million people every year, and climate change is now pushing disease-carrying species into regions — including Europe — where they were never seen before.
  • Google has formally asked the US government to approve the release of 64 million sterile male mosquitoes in California and Florida, a proposal that is as ambitious in scale as it is unconventional in origin.
  • The Wolbachia method works by flooding wild populations with males that cannot produce viable offspring, mathematically shrinking each generation of disease-carrying females without pesticides or genetic engineering.
  • Cyprus, Cuba, and China have already run successful pilots using similar sterile insect techniques, lending scientific credibility to what might otherwise seem like an audacious experiment.
  • Europe is tracking the outcome closely as its own mosquito crisis deepens — Aedes albopictus now thrives across 369 regions on the continent, and West Nile virus is appearing in places that had never recorded it before.

Mosquitoes are the deadliest animals on Earth, responsible for between 700,000 and one million deaths every year through diseases like dengue, malaria, yellow fever, Zika, and chikungunya. Google's Project Debug is now seeking US government approval to release 64 million sterile male mosquitoes across California and Florida over two years — an intervention designed not to kill mosquitoes outright, but to quietly dismantle their ability to reproduce.

The insects are bred in laboratories and infected with Wolbachia, a naturally occurring bacterium that prevents them from fathering viable offspring with wild females. When a sterile male mates in the field, the eggs don't hatch. Generation by generation, the wild population contracts, and with it, the chain of disease transmission. Because male mosquitoes don't bite, the releases pose no direct risk to humans. And because the method uses no toxins or genetic modification, the ecological footprint is minimal. Google has also developed software to ensure releases happen in the right volumes, at the right locations, at the right times.

The primary target is Aedes aegypti, the species behind roughly 40 percent of global mosquito-borne disease risk. Other countries have already walked this road: Cyprus released 100,000 sterile males weekly throughout 2023 after detecting the species on the island for the first time; Cuba and China ran their own trials years earlier. All reported meaningful success.

The urgency behind Google's proposal is sharpened by what is happening in Europe. Climate change is expanding mosquito habitats — Aedes albopictus now thrives across 369 European regions, up from 114 a decade ago, and West Nile virus is appearing in Italian and Romanian provinces where it was previously unknown. Public health authorities recommend removing standing water, applying larvicides to larger water bodies, and deploying adulticides during active outbreaks — but these are reactive measures with limited reach.

A coordinated strategy that pairs sterile insect releases with public health action represents something more structural: a way to address the problem at the population level before cases accumulate. If the US approves Project Debug, it will be the largest real-world test of whether that vision can hold.

Mosquitoes kill more people than any other animal on Earth—somewhere between 700,000 and a million deaths every year. They are vectors for dengue, malaria, yellow fever, Zika, and chikungunya, diseases that together claim tens of thousands of lives annually. Now Google is asking the United States government for permission to release 64 million of them.

The company's Project Debug proposes to flood California and Florida with sterile male mosquitoes over two years. These are not wild insects. They have been bred in laboratories and infected with Wolbachia, a naturally occurring bacterium that renders them unable to father offspring with wild females. When a sterile male mates with a disease-carrying female in the field, her eggs will not hatch. With each generation, the wild population shrinks. The transmission chain breaks.

The logic is elegant and chemical-free. Unlike pesticides or insecticides, which can damage ecosystems and harm non-target species, the Wolbachia approach uses no toxins and involves no genetic modification. Male mosquitoes do not bite humans and cannot transmit disease—only females feed on blood, which they need as protein to develop eggs. By flooding the environment with sterile males, Google's team aims to mathematically overwhelm the breeding population. The company has built software and monitoring tools to ensure the right number of insects are released in the right places at the right time.

The target is the Aedes aegypti mosquito, a species responsible for roughly 40 percent of the world's mosquito-borne disease risk. It is the primary vector for dengue, Zika, yellow fever, and chikungunya. Other countries have already tested similar approaches. Cyprus released 100,000 sterile males weekly for over 20 weeks in 2023, after detecting Aedes aegypti on the island in 2022—the first sign that the species had reached Europe. The Cypriot program used irradiation to sterilize the insects, a technique borrowed from agricultural pest management. Cuba ran trials in 2020. China did the same in 2017. All reported success.

Europe is watching closely because the mosquito landscape there is shifting rapidly. Climate change is lengthening transmission seasons, warming winters, and altering rainfall patterns. The Aedes albopictus mosquito, which spreads dengue, chikungunya, and Zika, now thrives in 16 European countries and 369 regions—up from 114 regions a decade ago. West Nile virus cases are appearing in new areas: the Italian provinces of Latina and Frosinone, Sălaj County in Romania. The European Centre for Disease Prevention and Control has warned that as mosquito-borne disease spreads, prevention becomes urgent. Removing standing water from flowerpots, buckets, and gutters can limit breeding grounds. Larger water bodies can be treated with larvicides. During active outbreaks, adulticides can be deployed, though always with ecological impact in mind.

But these measures are reactive and limited in scope. A coordinated strategy combining sterile insect releases with public health action and personal protection offers a different path—one that addresses the problem at the population level rather than waiting for cases to appear. Google's proposal, if approved, would test whether that approach can work at scale in the United States. The stakes are high. As temperatures rise and mosquitoes expand their range, the number of people at risk will only grow.

The presence of invasive mosquitoes introduced significant challenges to Cyprus, and if Aedes aegypti is not eradicated, could have serious consequences for all of Europe.
— Rafael Mariano Grossi, director general of the International Atomic Energy Agency
As the mosquito-borne disease landscape evolves, more people in Europe will be at risk in the future. This makes prevention more important than ever.
— Céline Gossner, senior expert in emerging and vector-borne disease at the ECDC
La Conversación del Hearth Otra perspectiva de la historia
Inventor

Why male mosquitoes? Why not just kill them all?

Model

Because you can't kill them all. They're everywhere, they breed fast, and pesticides damage everything else in the ecosystem. But if you flood the zone with sterile males, nature does the work for you—the wild females mate with them, lay eggs that never hatch, and the population collapses on its own.

Inventor

And Wolbachia is safe? It's a real bacterium, not something engineered?

Model

It occurs naturally in many insect species. Google isn't creating it or modifying the mosquitoes' genes. They're just infecting the males with something that already exists in nature. No toxins, no genetic engineering, no ecological wildcards.

Inventor

Has anyone actually done this before at scale?

Model

Cyprus released 100,000 sterile males every week for months in 2023. Cuba and China ran trials years earlier. They all worked. But Google's proposal is bigger—64 million over two years in two states. That's a different order of magnitude.

Inventor

What's the risk if something goes wrong?

Model

The males can't reproduce with wild females anyway, so there's no way to accidentally create a new population. The worst case is the program doesn't work and you have to try something else. But the real risk is doing nothing while mosquitoes keep spreading north and killing more people.

Inventor

Why is Europe so worried about this?

Model

Because Aedes aegypti is already there. It showed up in Cyprus in 2022. If it establishes itself across Europe, dengue and Zika become endemic diseases here too. Climate change is making that more likely every year. They're watching what Google does in California and Florida because they might need to do the same thing soon.

Quieres la nota completa? Lee el original en Euronews ↗
Contáctanos FAQ